Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

130.29
Delayed Data
As of Aug 22
 +2.86 / +2.24%
Today’s Change
96.93
Today|||52-Week Range
139.00
+12.56%
Year-to-Date

Today’s Trading

Previous close127.43
Today’s open128.14
Day’s range128.14 - 130.73
Volume2,797,496
Average volume (3 months)3,758,398
Market cap$99.7B
Dividend yield--
Data as of 08/22/2017

Growth & Valuation

Earnings growth (last year)+28.35%
Earnings growth (this year)+23.17%
Earnings growth (next 5 years)+21.84%
Revenue growth (last year)+22.70%
P/E ratio40.5
Price/Sales8.51
Price/Book15.03

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline+0.45+1.16%
BMYBristol-Myers Squibb+1.03+1.82%
NVONovo Nordisk+0.69+1.52%
ABBVAbbVie+1.05+1.49%
Data as of 08/22/2017

Financials

Next reporting dateOctober 26, 2017
EPS forecast (this quarter)$1.88
Annual revenue (last year)$10.9B
Annual profit (last year)$2.0B
Net profit margin18.30%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark J. Alles
President &
Chief Operating Officer
Scott Andrew Smith
Corporate headquarters
Summit, New Jersey

Forecasts